Your Unread Messages
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
The value of drugs for obesity in the management of cardiovascular risk factors
Sang Thrombose Vaisseaux, 11/04/09
Czernichow S et al. – Clinical trials show that the expected weight loss is 3 to 4 Kg compared with placebo. In addition, orlistat should improve blood sugar and lipid levels and reduce blood pressure. Sibutramine increases HDL cholesterol, decreases triglycerides but increases the blood pressure and heart rate. A trial is underway to study the impact of these adverse effects in subjects at high cardiovascular risk. Therefore, the field for the development of new drugs for treating overweight and obesity remains wide open.
Related Articles
Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: A matched-pair cohort study
Arthritis & Rheumatism, 11/05/09
Relevance Score: 71%
Chronic renal insufficiency, cardiovascular disease and mortality in women: a causal relationship or coincidence?
Women's Health, 11/02/09
Relevance Score: 70%
Cardiovascular morbidity and mortality remain similar in two cohorts of patients with long-standing rheumatoid arthritis seen in 1978 and 1995 in Malmö, Sweden
Rheumatology, 10/30/09
Relevance Score: 70%
Frequency of migraine and the risk of cardiovascular disease for women: limited evidence of an association
Women's Health, 10/30/09
Relevance Score: 69%
Systemic lupus erythematosus and the risk of cardiovascular disease: Results from the Nurses Health Study
Arthritis Care and Research, 10/01/09
Relevance Score: 69%
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Managing Mixed Dyslipidemia in Special Populations
Preventive Cardiology, 11/24/09
Understanding Omega-3 Polyunsaturated Fatty Acids
Postgraduate Medicine, 11/24/09
Colesevelam HCl Improves Fasting Plasma Glucose and Lipid Levels in Patients with Prediabetes
Postgraduate Medicine, 11/23/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect
Bipolar Disorders, 11/24/09
Antipsychotic Prescribing Practices Following Withdrawal of Concomitant Carbamazepine
Journal of Psychiatric Practice, 11/24/09
Impact of pharmaceutical dosage form on stability and dissolution of roxithromycin
Central European Journal of Medicine, 11/24/09
Today in Vascular Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
How Stiff Are Your Arteries? An Emerging Vital Sign for Determining Cardiovascular Disease Risk
The Journal for Nurse Practitioners , 11/24/09
Connective Tissue Reflex Massage for Type 2 Diabetic Patients with Peripheral Arterial Disease: Randomized Controlled Trial
Evidence-based Complementary and Alternative Medicine , 11/24/09
YKL-40 - an emerging biomarker in cardiovascular disease and diabetes
Cardiovascular Diabetology, 11/24/09
Sponsor
Article Search
Sponsor
Sponsor


See All


